Central - Tenders Closing for a specific Date

Report For Day : 08-Jul-2026

Total Tenders : 2167
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
1431. 05-Jul-2026 06:56 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:00 PM (PH NO.:02031) LIGNOCAINE 2 Percent (AQUEOUS SOLUTION INJ. EQUIVALENT TO 21.3 MG/ML) 50 ML INJ,UNIT:VIAL/SCRLGD26203110175R3/90459363 Ministry of Railways --
1432. 05-Jul-2026 07:09 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:00 PM (PH NO.:03110) DICLOFENAC 75 MG/1 ML INJ,UNIT:AMPOULE/SCRLGD263110177R1/90459370 Ministry of Railways --
1433. 05-Jul-2026 07:18 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:00 PM (PH NO.:09055) ETIZOLAM 0.5 MG TAB,UNIT:TABLET/SCRLGD26905510180R1/90459384 Ministry of Railways --
1434. 05-Jul-2026 07:30 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:00 PM (PH NO.:11001) PRALIDOXIME (PAM) HCL 500 MG-20 ML INJ,UNIT:VIAL/SCRLGD261100110182R2/90459395 Ministry of Railways --
1435. 05-Jul-2026 08:15 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:00 PM (PH NO.:16015) ARTESUNATE 60 MG INJ,UNIT:VIAL/SCRLGD261601510185R1/90459484 Ministry of Railways --
1436. 05-Jul-2026 08:25 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:00 PM (PH NO.:18015) DROTAVERINE HCL 40 MG/ 2 ML INJ,UNIT:AMPOULE/SCRLGD261801510186R1/90459501 Ministry of Railways --
1437. 01-Jul-2026 12:34 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:30 PM 69/2026-27/HYD-III/HYD(CE NIT NO.14/CE-HYD/2026-27)/69/2026-27/HYD-III/HYD(CE NIT NO.14/CE-HYD/2026-27)/159939 Central Public Works Department (CPWD) --
1438. 01-Jul-2026 12:22 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:30 PM 17/EE/GCD/2026-27/17/EE/GCD/2026-27/159961 Central Public Works Department (CPWD) --
1439. 01-Jul-2026 12:21 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:30 PM 21/EE/C1D/CPWD/CHENNAI/2026-27/21/EE/C1D/CPWD/CHENNAI/2026-27/159960 Central Public Works Department (CPWD) --
1440. 01-Jul-2026 12:05 AM 08-Jul-2026 03:00 PM 08-Jul-2026 03:30 PM 10/EE/GCD/2026-27/R1/10/EE/GCD/2026-27/R1/159959 Central Public Works Department (CPWD) --

Note : For more details and clarifications, please refer to the respective Portal.